Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol. 2019 Feb 01;:
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Curr Oncol. 2018 Oct;25(5):317-328
N Engl J Med. 2018 01 11;378(2):113-125
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.
Clin Colorectal Cancer. 2017 Oct 23;:
Target Oncol. 2017 Aug 11;:
Clin Lung Cancer. 2017 Jan 05;:
Clin Lung Cancer. 2016 Oct 26;:
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.
Ann Oncol. 2016 Oct 11;:
Curr Oncol. 2016 Aug;23(4):e435
176P: ALK-rearranged non-small cell lung cancer is associated with a high rate of venous thromboembolism.
J Thorac Oncol. 2016 Apr;11(4 Suppl):S134